Viewing Study NCT03239392


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-24 @ 8:47 AM
Study NCT ID: NCT03239392
Status: COMPLETED
Last Update Posted: 2021-05-25
First Post: 2017-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Sponsor: Bioniz Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None LGL Leukemia View
None CTCL View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BNZ-1 View
None Cytokine View
None IL-2 View
None IL-15 View